Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that its Board of Directors has appointed Dr. Ivan Trifunovich as the company's President and Chief Executive Officer.
Dr. Trifunovich has served as a senior consultant to the...
Single-molecule sequencing technology has detected and quantified novel small RNAs in human cells that represent entirely new classes of the gene-translating molecules, confirming a long-held but unproven hypothesis that mammalian cells are...
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Helicos+%28HLCS%29+Implementing+Strategic+Shift+Toward+Diagnostics%3B+to+Cut+40+Jobs+This+Quarter/5645494.html for the full story.
The most extensive analysis of one
person’s DNA, for a Stanford University gene-mapping innovator,
found what drugs might help him best and revealed his risk of
diabetes and a rare heart condition that can cause sudden death.
CALGARY, Alberta, April 14, 2010 (GLOBE NEWSWIRE) -- Liberty Analytics Co., a leading provider of large, small- and micro-cap independent investment research, today initiated coverage on Helicos BioSciences Corp. (Nasdaq:HLCS). Liberty Analytics is
DALLAS, Jan. 21, 2010 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring Helicos BioSciences Corp. (Nasdaq:HLCS). The report includes financial and investment analysis, analyst consensus, and pertinent industry information
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.